Advisory Committee on Immunization Practices, 49653-49654 [2020-17765]

Download as PDF Federal Register / Vol. 85, No. 158 / Friday, August 14, 2020 / Notices Quality, (40 CFR parts 1500 to 1508), this notice advises the public of our finding that the Proposed Action will not significantly affect the quality of the human environment. Basis for Finding The environmental impacts of the proposed repairs and alterations were considered in the Final EA pursuant to the National Environmental Policy Act (NEPA) and the CEQ regulations implementing NEPA. No significant impacts on the environment would occur with implementation of best management practices and avoidance, minimization, and mitigation measures identified in the Final EA. The Final EA and Finding of No Significant Impact (FONSI) can be viewed on the GSA website at https:// www.gsa.gov/about-us/regions/ welcome-to-the-pacific-rim-region-9/ buildings-and-facilities/california/usappraisers-building and https:// www.gsa.gov/about-us/regions/ welcome-to-the-pacific-rim-region-9/ buildings-and-facilities/california/uscustom-house-san-francisco (The Final EA is located under the ‘‘Current Projects’’ section). The FONSI will be signed thirty (30) days after the publication of this notice, provided that no information leading to the contrary finding is received or comes to light during this period. Dated: August 11, 2020. Jared Bradley, Director, Portfolio Management Division, Pacific Rim Region, Public Buildings Service. [FR Doc. 2020–17804 Filed 8–13–20; 8:45 am] BILLING CODE 6820–YF–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket No. CDC–2020–0093] Advisory Committee on Immunization Practices Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting and request for comment. khammond on DSKJM1Z7X2PROD with NOTICES AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), announces the following meeting of the Advisory Committee on Immunization Practices (ACIP). This meeting is open to the public. Time will be available for public SUMMARY: VerDate Sep<11>2014 17:29 Aug 13, 2020 Jkt 250001 comment. The meeting will be webcast live via the World Wide Web. DATES: The meeting will be held on September 22, 2020 from 10:00 a.m. to 4:00 p.m., EDT (times subject to change). Written comments must be received on or before September 23, 2020. ADDRESSES: For more information on ACIP please visit the ACIP website: https://www.cdc.gov/vaccines/acip/ index.html. You may submit comments, identified by Docket No. CDC–2020–0093 by any of the following methods: • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. • Mail: Docket No. CDC–2020–0093, c/o Attn: September ACIP Meeting, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H24–8, Atlanta, GA 30329–4027. Instructions: All submissions received must include the Agency name and Docket Number. All relevant comments received in conformance with the https://www.regulations.gov suitability policy will be posted without change to https://www.regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to https://www.regulations.gov. FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee Management Specialist, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, 1600 Clifton Road, NE, MS–H24–8, Atlanta, GA 30329– 4027; Telephone: 404–639–8367; Email: ACIP@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The committee is charged with advising the Director, CDC, on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding dosing interval, dosage, and contraindications to administration of vaccines. Further, under provisions of the Affordable Care Act, section 2713 of the Public Health Service Act, immunization recommendations of the ACIP that have been approved by the Director of the Centers for Disease Control and Prevention and appear on CDC immunization schedules must be covered by applicable health plans. Matters to be Considered: The agenda will include discussions on COVID–19 vaccines. No recommendation votes are PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 49653 scheduled. Agenda items are subject to change as priorities dictate. For more information on the meeting agenda visit https://www.cdc.gov/vaccines/acip/ meetings/meetings-info.html. Meeting Information: The meeting will be webcast live via the World Wide Web; for more information on ACIP please visit the ACIP website: https:// www.cdc.gov/vaccines/acip/. Public Participation Interested persons or organizations are invited to participate by submitting written views, recommendations, and data. Comments received are part of the public record and are subject to public disclosure. Do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. If you include your name, contact information, or other information that identifies you in the body of your comments, that information will be on public display. CDC will review all submissions and may choose to redact, or withhold, submissions containing private or proprietary information such as Social Security numbers, medical information, inappropriate language, or duplicate/ near duplicate examples of a mass-mail campaign. CDC will carefully consider all comments submitted into the docket. CDC does not accept comment by email. Oral Public Comment: This meeting will include time for members of the public to make an oral comment. Oral public comment will occur before any scheduled votes including all votes relevant to the ACIP’s Affordable Care Act and Vaccines for Children Program roles. Priority will be given to individuals who submit a request to make an oral public comment before the meeting according to the procedures below. Procedure for Oral Public Comment: All persons interested in making an oral public comment at the August ACIP meeting must submit a request at https:// www.cdc.gov/vaccines/acip/meetings/ no later than 11:59 p.m., EDT, September 16, 2020 according to the instructions provided. If the number of persons requesting to speak is greater than can be reasonably accommodated during the scheduled time, CDC will conduct a lottery to determine the speakers for the scheduled public comment session. CDC staff will notify individuals regarding their request to speak by email by September 18, 2020. To accommodate the significant interest in participation in the oral public comment session of ACIP meetings, each speaker will be limited to 3 E:\FR\FM\14AUN1.SGM 14AUN1 49654 Federal Register / Vol. 85, No. 158 / Friday, August 14, 2020 / Notices minutes, and each speaker may only speak once per meeting. Written Public Comment: Written comments must be received on or before September 23, 2020. Written public comments submitted by 72 hours prior to the ACIP meeting will be provided to ACIP members before the meeting. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2020–17765 Filed 8–13–20; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–10418, CMS– 10199, CMS–R–52 and CMS–R–26] Agency Information Collection Activities: Submission for OMB Review; Comment Request Centers for Medicare & Medicaid Services, HHS. ACTION: Notice. AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:29 Aug 13, 2020 Jkt 250001 to the Secretary concerning the amount the issuer spends each year on claims, quality improvement expenses, nonDATES: Comments on the collection(s) of claims costs, Federal and State taxes information must be received by the and licensing and regulatory fees, the OMB desk officer by September 14, amount of earned premium, and 2020. beginning with the 2014 reporting year, ADDRESSES: Written comments and the amounts related to the transitional recommendations for the proposed reinsurance, risk corridors, and risk information collection should be sent adjustment programs established under within 30 days of publication of this sections 1341, 1342, and 1343, notice to www.reginfo.gov/public/do/ respectively, of the Affordable Care Act. PRAMain. Find this particular An issuer must provide an annual rebate information collection by selecting if the amount it spends on certain costs ‘‘Currently under 30-day Review—Open compared to its premium revenue for Public Comments’’ or by using the (excluding Federal and States taxes and search function. licensing and regulatory fees) does not To obtain copies of a supporting meet a certain ratio, referred to as the statement and any related forms for the medical loss ratio (MLR). Each issuer is proposed collection(s) summarized in required to submit annually MLR data, this notice, you may make your request including information about any rebates using one of following: it must provide, on a form prescribed by 1. Access CMS’ website address at CMS, for each State in which the issuer website address at https://www.cms.gov/ conducts business. Each issuer is also Regulations-and-Guidance/Legislation/ required to provide a rebate notice to PaperworkReductionActof1995/PRAeach policyholder that is owed a rebate Listing.html. and each subscriber of policyholders 2. Call the Reports Clearance Office at that are owed a rebate for any given (410) 786–1326. MLR reporting year. Additionally, each issuer is required to maintain for a FOR FURTHER INFORMATION CONTACT: period of seven years all documents, William Parham at (410) 786–4669. records and other evidence that support SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) the data included in each issuer’s annual report to the Secretary. (44 U.S.C. 3501–3520), federal agencies Based upon CMS’ experience in the must obtain approval from the Office of Management and Budget (OMB) for each MLR data collection and evaluation process, CMS is updating its annual collection of information they conduct burden hour estimates to reflect the or sponsor. The term ‘‘collection of actual numbers of submissions, rebates information’’ is defined in 44 U.S.C. and rebate notices. The 2019 MLR 3502(3) and 5 CFR 1320.3(c) and Reporting Form and Instructions reflect includes agency requests or requirements that members of the public changes for the 2018 reporting year and submit reports, keep records, or provide beyond. The 2019 MLR Reporting Form and instructions are also modified to information to a third party. Section eliminate the reporting elements that 3506(c)(2)(A) of the PRA (44 U.S.C. were required under the risk corridors 3506(c)(2)(A)) requires federal agencies data submission requirements in 45 CFR to publish a 30-day notice in the 153.530 for the 2014 through 2016 Federal Register concerning each benefit years. For 2019, it is expected proposed collection of information, that issuers will submit fewer reports including each proposed extension or and on average, send fewer notices and reinstatement of an existing collection rebate checks in the mail to of information, before submitting the policyholders and subscribers, which collection to OMB for approval. To will reduce burden on issuers. In comply with this requirement, CMS is addition, issuers of qualified health publishing this notice that summarizes plans will no longer have to submit on the following proposed collection(s) of the annual report the data for the risk information for public comment: corridors program established under 1. Type of Information Collection section 1342 of the Patient Protection Request: Revision of a currently and Affordable Care Act. Form Number: approved collection; Title of CMS–10418 (OMB control number: Information Collection: Annual MLR and Rebate Calculation Report and MLR 0938–1164); Frequency: Annually; Affected Public: Private Sector, Business Rebate Notices; Use: Under Section or other for-profit and not-for-profit 2718 of the Affordable Care Act and implementing regulation at 45 CFR part institutions; Number of Respondents: 494; Number of Responses: 1,896; Total 158, a health insurance issuer (issuer) Annual Hours: 232,427. For policy offering group or individual health insurance coverage must submit a report questions regarding this collection minimize the information collection burden. PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\14AUN1.SGM 14AUN1

Agencies

[Federal Register Volume 85, Number 158 (Friday, August 14, 2020)]
[Notices]
[Pages 49653-49654]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-17765]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2020-0093]


Advisory Committee on Immunization Practices

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC), announces the 
following meeting of the Advisory Committee on Immunization Practices 
(ACIP). This meeting is open to the public. Time will be available for 
public comment. The meeting will be webcast live via the World Wide 
Web.

DATES: The meeting will be held on September 22, 2020 from 10:00 a.m. 
to 4:00 p.m., EDT (times subject to change).
    Written comments must be received on or before September 23, 2020.

ADDRESSES: For more information on ACIP please visit the ACIP website: 
https://www.cdc.gov/vaccines/acip/.
    You may submit comments, identified by Docket No. CDC-2020-0093 by 
any of the following methods:
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: Docket No. CDC-2020-0093, c/o Attn: September ACIP 
Meeting, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H24-8, Atlanta, GA 30329-4027.
    Instructions: All submissions received must include the Agency name 
and Docket Number. All relevant comments received in conformance with 
the https://www.regulations.gov suitability policy will be posted 
without change to https://www.regulations.gov, including any personal 
information provided. For access to the docket to read background 
documents or comments received, go to https://www.regulations.gov.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee 
Management Specialist, Centers for Disease Control and Prevention, 
National Center for Immunization and Respiratory Diseases, 1600 Clifton 
Road, NE, MS-H24-8, Atlanta, GA 30329-4027; Telephone: 404-639-8367; 
Email: [email protected].

SUPPLEMENTARY INFORMATION:
    Purpose: The committee is charged with advising the Director, CDC, 
on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, 
the committee is mandated to establish and periodically review and, as 
appropriate, revise the list of vaccines for administration to vaccine-
eligible children through the Vaccines for Children (VFC) program, 
along with schedules regarding dosing interval, dosage, and 
contraindications to administration of vaccines. Further, under 
provisions of the Affordable Care Act, section 2713 of the Public 
Health Service Act, immunization recommendations of the ACIP that have 
been approved by the Director of the Centers for Disease Control and 
Prevention and appear on CDC immunization schedules must be covered by 
applicable health plans.
    Matters to be Considered: The agenda will include discussions on 
COVID-19 vaccines. No recommendation votes are scheduled. Agenda items 
are subject to change as priorities dictate. For more information on 
the meeting agenda visit https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html.
    Meeting Information: The meeting will be webcast live via the World 
Wide Web; for more information on ACIP please visit the ACIP website: 
https://www.cdc.gov/vaccines/acip/.

Public Participation

    Interested persons or organizations are invited to participate by 
submitting written views, recommendations, and data. Comments received 
are part of the public record and are subject to public disclosure. Do 
not include any information in your comment or supporting materials 
that you consider confidential or inappropriate for public disclosure. 
If you include your name, contact information, or other information 
that identifies you in the body of your comments, that information will 
be on public display. CDC will review all submissions and may choose to 
redact, or withhold, submissions containing private or proprietary 
information such as Social Security numbers, medical information, 
inappropriate language, or duplicate/near duplicate examples of a mass-
mail campaign. CDC will carefully consider all comments submitted into 
the docket. CDC does not accept comment by email.
    Oral Public Comment: This meeting will include time for members of 
the public to make an oral comment. Oral public comment will occur 
before any scheduled votes including all votes relevant to the ACIP's 
Affordable Care Act and Vaccines for Children Program roles. Priority 
will be given to individuals who submit a request to make an oral 
public comment before the meeting according to the procedures below.
    Procedure for Oral Public Comment: All persons interested in making 
an oral public comment at the August ACIP meeting must submit a request 
at https://www.cdc.gov/vaccines/acip/meetings/ no later than 11:59 p.m., 
EDT, September 16, 2020 according to the instructions provided.
    If the number of persons requesting to speak is greater than can be 
reasonably accommodated during the scheduled time, CDC will conduct a 
lottery to determine the speakers for the scheduled public comment 
session. CDC staff will notify individuals regarding their request to 
speak by email by September 18, 2020. To accommodate the significant 
interest in participation in the oral public comment session of ACIP 
meetings, each speaker will be limited to 3

[[Page 49654]]

minutes, and each speaker may only speak once per meeting.
    Written Public Comment: Written comments must be received on or 
before September 23, 2020. Written public comments submitted by 72 
hours prior to the ACIP meeting will be provided to ACIP members before 
the meeting.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-17765 Filed 8-13-20; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.